Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravesical Alkalinized Lidocaine-Heparin for Pelvic Pain
NCT00256542Phase 2Completed
- Sponsor
- Urigen Pharmaceuticals, Inc.
- Start
- Jan 2006
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of lidocaine and heparin in interstitial cystitis (IC) and pelvic pain (2 arms), sponsored by Urigen Pharmaceuticals, Inc. Primary endpoint: Overall improvement in combined symptoms of pain and urgency at 3 weeks. Started Jan 2006; status: completed.
02
Drugs
lidocaineheparin
03
Conditions
interstitial cystitis (IC)pelvic pain
Beyond the preview
Go deeper on NCT00256542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00256542.